SciSparc Ltd. (NASDAQ:SPRC) began trading on the NASDAQ last month. It is a clinical stage pharmaceutical company with multiple catalysts. It has clinical trials set this year for its proprietary drug candidates. This Tel Aviv-based Company has a full portfolio of patented treatments and therapies focused on the central nervous system. It applies unique technologies… Continue reading SciSparc Ltd. (NASDAQ:SPRC) Uplists To NASDAQ, Full Pipeline Of Clinical Trials Set For 2022